Tumor marker CA 11-19 as a new serum blood test for monitoring colorectal cancer.

医学 结直肠癌 内科学 胃肠病学 粪便潜血 癌症 癌胚抗原 肿瘤标志物 阶段(地层学) 抗原 血液检验 肿瘤科 结肠镜检查 免疫学 生物 古生物学
作者
John J. Costanzi,T. Jordan,Lisa Jensen-long
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:34 (4_suppl): 536-536
标识
DOI:10.1200/jco.2016.34.4_suppl.536
摘要

536 Background: Colorectal cancer remains the third most frequent cause of cancer deaths globally. The FOBT (fecal occult blood test) and FIT (fecal immunochemical test) as well as CEA are increasingly being used to screen or monitor patients at increased risk for colorectal cancer (CRC), however none has optimal performance in terms of both sensitivity and specificity. Data was recently published* on the new serum blood test colorectal tumor marker CA11-19. This data showed a sensitivity of 98% (95% CI, 93.1%-99.5%) and specificity of 84% (95% CI, 80.0%-87.9%) at a cut-off value of 6.5 U/mL with a high sensitivity for detection of early stage CRC as opposed to CEA whose values are reported ~40% and ~30–80%** respectively for sensitivity and specificity. This study will look at case studies that show an array of long-term monitoring outcomes which suggest possible use of CA 11-19 instead of CEA. Methods: Using a sandwich ELISA assay, a new colon cancer antigen, CA 11-19, (100 kDa glycoprotein) was measured in samples of 7 patients with a variety of conditions in normal, benign GI diseases, polyps and colon cancer. This long-term follow up is recorded from 8 to 20 years. Results: Serum samples previously frozen were used to measure the CA11-19 antigen. An average follow up time of 15 years (range 8 to 20 years) was recorded. Elevated levels of CA11-19 were detected in patients with polyps and CRC prior to treatment and decreased levels were measured after the removal of the polyps or cancer. Importantly, rising rates of CA11-19 were seen in patients with cancer recurrences of colorectal cancers. Conclusions: CA 11-19 is a serologic tumor marker for colorectal cancer with a published sensitivity of 97.7% and a specificity of 84.4%*. Preliminary reports from 7 cases show long-term data which could be more helpful in monitoring and or follow-up of high risk patients for CRC than the current CEA testing method. Additional studies are needed to further validate the use of CA 11-19 in these patient groups.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
为你钟情完成签到 ,获得积分10
1秒前
4秒前
5秒前
韭菜盒子发布了新的文献求助10
7秒前
潘特发布了新的文献求助10
10秒前
乌滴子完成签到,获得积分10
11秒前
量子星尘发布了新的文献求助10
12秒前
善学以致用应助韭菜盒子采纳,获得10
12秒前
jiaaniu完成签到 ,获得积分10
14秒前
清脆靳完成签到,获得积分10
15秒前
cp3xzh完成签到,获得积分10
15秒前
tian发布了新的文献求助10
17秒前
tian发布了新的文献求助10
17秒前
明理宛秋完成签到 ,获得积分10
18秒前
S月小小完成签到,获得积分10
22秒前
斯文的慕儿完成签到 ,获得积分10
29秒前
keen完成签到 ,获得积分10
29秒前
韭菜盒子完成签到,获得积分20
30秒前
潘特完成签到,获得积分10
31秒前
小彭友完成签到,获得积分10
42秒前
43秒前
josie完成签到 ,获得积分10
47秒前
llll完成签到 ,获得积分10
47秒前
量子星尘发布了新的文献求助10
47秒前
韭菜发布了新的文献求助10
47秒前
外向的斑马完成签到 ,获得积分10
48秒前
村长热爱美丽完成签到 ,获得积分10
50秒前
尹尹关注了科研通微信公众号
52秒前
呆呆完成签到 ,获得积分10
53秒前
xianyaoz完成签到 ,获得积分0
1分钟前
杨远杰完成签到,获得积分10
1分钟前
蓝桉完成签到 ,获得积分10
1分钟前
JuliaWang完成签到 ,获得积分10
1分钟前
无限的含羞草完成签到,获得积分10
1分钟前
八二力完成签到 ,获得积分10
1分钟前
韭菜发布了新的文献求助10
1分钟前
情怀应助科研通管家采纳,获得30
1分钟前
water应助科研通管家采纳,获得10
1分钟前
JamesPei应助科研通管家采纳,获得10
1分钟前
2012csc完成签到 ,获得积分0
1分钟前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022